Literature DB >> 814916

Bilateral juvenile xanthogranuloma of the iris.

O B Hadden.   

Abstract

Juvenile xanthogranuloma of the iris has only twice before been reported as occurring bilaterally. In this present bilateral case, treatment with steroids and irradiation was sucessful in eradicating the lesion from the lesser affected eye.

Entities:  

Mesh：

Year:  1975        PMID： 814916      PMCID： PMC1017438          DOI： 10.1136/bjo.59.12.699

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  6 in total

1.  [NEVOXANTHOENDOTHELIOMA WITH BILATERAL OCULAR INVOLVEMENT].

Authors:  A B RADIAN; A L RADIAN; J OSTFELD
Journal:  Ann Ocul (Paris)       Date:  1964-07

2.  JUVENILE XANTHOGRANULOMA: REPORT OF A CASE.

Authors:  J G MOORE; J HARRY
Journal:  Br J Ophthalmol       Date:  1965-02       Impact factor: 4.638

3.  Nevoxanthoendothelioma (juvenile xanthogranuloma) of the iris. Diagnosis by biopsy and treatment with x-ray.

Authors:  G W CLEASBY
Journal:  Arch Ophthalmol       Date:  1961-07

4.  Epibulbar nevoxanthoendothelioma.

Authors:  D G COGAN; T KUWABARA; D PARKE
Journal:  AMA Arch Ophthalmol       Date:  1958-05

5.  Juvenile xanthogranuloma of the cornea and conjunctiva.

Authors:  B Nordentoft; S R Andersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1967

6.  Juvenile oculodermal xanthogranuloma.

Authors:  J L Smith; R M Ingram
Journal:  Br J Ophthalmol       Date:  1968-09       Impact factor: 4.638
  6 in total
  3 in total

1.  [Unilateral corneal decompensation in a 6 month old infant].

Authors:  C E Uhlig; H Busse
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

2.  Recurrent hemorrhage in the anterior chamber caused by a (juvenile) xanthogranuloma of the iris in an adult.

Authors:  R F Brenkman; J A Oosterhuis; W A Manschot
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

3.  Early treatment of juvenile xanthogranuloma of the iris with subconjunctival steroids.

Authors:  I Casteels; J Olver; M Malone; D Taylor
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.